EVAXION BIOTECH A/S (EVAX)
US29970R2040 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -22.13M | -23.17M | -24.53M | -15.02M | -11.20M | |||
| Depreciation Amortization | 615.00K | 571.00K | 344.00K | 105.00K | 81.00K | |||
| Change In Working Capital | 3.09M | -2.29M | 2.06M | 997.00K | 1.22M | |||
| Interest Paid | 65.00K | 172.00K | 25.00K | 30.00K | 39.00K | |||
| Other non cash items | 725.00K | -881.00K | 197.00K | 1.48M | 2.87M | |||
| OPERATING CASH FLOW | -17.69M | -25.77M | -21.93M | -12.44M | -7.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -87.00K | -292.00K | -1.36M | -184.00K | -61.00K | |||
| Other Investing Activity | -6.00K | 24.00K | 30.00K | -209.00K | N/A | |||
| INVESTING CASH FLOW | -93.00K | -268.00K | -1.33M | -393.00K | -61.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -632.00K | 7.42M | -289.00K | -74.00K | 79.00K | |||
| Stock Issued/Repurchased | 11.76M | 428.00K | 53.85M | 9.02M | 9.44M | |||
| Other Financing Activity | -432.00K | 0.00 | -3.76M | -128.00K | -13.00K | |||
| FINANCING CASH FLOW | 10.69M | 7.85M | 49.80M | 8.82M | 9.51M | |||
| Exchange Rate Effect | -508.00K | -793.00K | -210.00K | 288.00K | -295.00K | |||
| CHANGE IN CASH | -7.60M | -18.98M | 26.33M | -3.73M | 2.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.69M | -25.77M | -21.93M | -12.44M | -7.03M | |||
| Capital Expenditure | -87.00K | -292.00K | -1.36M | -184.00K | -61.00K | |||
| FREE CASH FLOW | -17.78M | -26.07M | -23.29M | -12.62M | -7.09M | |||
All data in USD